These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34890138)

  • 41. Two-stage multivariate Mendelian randomization on multiple outcomes with mixed distributions.
    Deng Y; Tu D; O'Callaghan CJ; Liu G; Xu W
    Stat Methods Med Res; 2023 Aug; 32(8):1543-1558. PubMed ID: 37338962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severity of bias of a simple estimator of the causal odds ratio in Mendelian randomization studies.
    Harbord RM; Didelez V; Palmer TM; Meng S; Sterne JA; Sheehan NA
    Stat Med; 2013 Mar; 32(7):1246-58. PubMed ID: 23080538
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mendelian Randomization as an Approach to Assess Causality Using Observational Data.
    Sekula P; Del Greco M F; Pattaro C; Köttgen A
    J Am Soc Nephrol; 2016 Nov; 27(11):3253-3265. PubMed ID: 27486138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conditional inference in cis-Mendelian randomization using weak genetic factors.
    Patel A; Gill D; Newcombe P; Burgess S
    Biometrics; 2023 Dec; 79(4):3458-3471. PubMed ID: 37337418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combining Mendelian randomization and network deconvolution for inference of causal networks with GWAS summary data.
    Lin Z; Xue H; Pan W
    PLoS Genet; 2023 May; 19(5):e1010762. PubMed ID: 37200398
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimation of time-varying causal effects with multivariable Mendelian randomization: some cautionary notes.
    Tian H; Burgess S
    Int J Epidemiol; 2023 Jun; 52(3):846-857. PubMed ID: 36661066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pleiotropy-robust Mendelian randomization.
    van Kippersluis H; Rietveld CA
    Int J Epidemiol; 2018 Aug; 47(4):1279-1288. PubMed ID: 28338774
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of allele scores as instrumental variables for Mendelian randomization.
    Burgess S; Thompson SG
    Int J Epidemiol; 2013 Aug; 42(4):1134-44. PubMed ID: 24062299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bias in two-sample Mendelian randomization when using heritable covariable-adjusted summary associations.
    Hartwig FP; Tilling K; Davey Smith G; Lawlor DA; Borges MC
    Int J Epidemiol; 2021 Nov; 50(5):1639-1650. PubMed ID: 33619569
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessment of causality between serum gamma-glutamyltransferase and type 2 diabetes mellitus using publicly available data: a Mendelian randomization study.
    Noordam R; Smit RA; Postmus I; Trompet S; van Heemst D
    Int J Epidemiol; 2016 Dec; 45(6):1953-1960. PubMed ID: 28031309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Causal effects of atrial fibrillation on brain white and gray matter volume: a Mendelian randomization study.
    Park S; Lee S; Kim Y; Cho S; Kim K; Kim YC; Han SS; Lee H; Lee JP; Lee S; Choi EK; Joo KW; Lim CS; Kim YS; Kim DK
    BMC Med; 2021 Nov; 19(1):274. PubMed ID: 34814924
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Avoiding bias from weak instruments in Mendelian randomization studies.
    Burgess S; Thompson SG;
    Int J Epidemiol; 2011 Jun; 40(3):755-64. PubMed ID: 21414999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modifiable environmental exposure and risk of rheumatoid arthritis-current evidence from genetic studies.
    Jiang X; Alfredsson L
    Arthritis Res Ther; 2020 Jun; 22(1):154. PubMed ID: 32571398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of body mass index and blood pressure on atrioventricular block: Two-sample mendelian randomization.
    Chi X; Zhang N; Zhang L; Fan F; Jia J; Xu M; Li J
    Heart Rhythm; 2024 Feb; 21(2):174-183. PubMed ID: 37918507
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study.
    Morales Berstein F; McCartney DL; Lu AT; Tsilidis KK; Bouras E; Haycock P; Burrows K; Phipps AI; Buchanan DD; Cheng I; ; Martin RM; Davey Smith G; Relton CL; Horvath S; Marioni RE; Richardson TG; Richmond RC
    Elife; 2022 Mar; 11():. PubMed ID: 35346416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are neurodegenerative diseases associated with an increased risk of inflammatory bowel disease? A two-sample Mendelian randomization study.
    Cui G; Li S; Ye H; Yang Y; Huang Q; Chu Y; Shi Z; Zhang X
    Front Immunol; 2022; 13():956005. PubMed ID: 36159838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.
    Hartwig FP; Davey Smith G; Bowden J
    Int J Epidemiol; 2017 Dec; 46(6):1985-1998. PubMed ID: 29040600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Integrating multi-omics summary data using a Mendelian randomization framework.
    Jin C; Lee B; Shen L; Long Q; ;
    Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36094096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Constrained instruments and their application to Mendelian randomization with pleiotropy.
    Jiang L; Oualkacha K; Didelez V; Ciampi A; Rosa-Neto P; Benedet AL; Mathotaarachchi S; Richards JB; Greenwood CMT;
    Genet Epidemiol; 2019 Jun; 43(4):373-401. PubMed ID: 30635941
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of two-sample methods for Mendelian randomization analyses on single large datasets.
    Minelli C; Del Greco M F; van der Plaat DA; Bowden J; Sheehan NA; Thompson J
    Int J Epidemiol; 2021 Nov; 50(5):1651-1659. PubMed ID: 33899104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.